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Background: Restricting antibiotics sales to those with medical prescriptions only is a central strategy for
promoting appropriate use and containing antibiotic resistance; however, many low and middle income countries
have not enforced policies that prevent widespread self-medication with antibiotics. In 2010, the Mexican
government announced the enforcement of antibiotic sales regulations, a policy that gained media prominence.
This study analyzes media coverage of issues, stakeholder representation, and positions taken during policy agenda
setting, drafting, and implementation to shed light on policy making to promote appropriate antibiotic utilization.
Methods: We carried out a quantitative content analysis of 322 newspaper articles published between January
2009 and December 2010 in 18 national and regional newspapers. Additionally, we conducted a qualitative content
analysis to understand the positions adopted and strategies developed by nine key stakeholders. Framing theory
guided the analysis.
Results: The Ministry of Health dominated media coverage, justifying the enforcement policy by focusing on risks
of self-medication, and to a lesser degree dangers of increasing antibiotic resistance. Pharmacy associations
appeared to be the leading opponents, arguing that the policy created logistical difficulties and corruption, and
had negative economic impact for pharmacies and their clients. The associations developed strategies against the
regulation such as attempting to delay implementation and installing physicians’ consultation offices within
pharmacies. While medical associations and academic institutions called for a comprehensive strategy to combat
antibiotic resistance, improve prescription quality, and create public awareness, these issues had little impact on
media coverage. Consumer groups and legislators received very little media coverage.
Conclusions: The narrowly-focused and polarized media coverage ─centred on problems of self- medication and
economic impact ─ was a missed opportunity to publicly discuss and to develop a comprehensive national
strategy on antibiotic use in Mexico. It highlights the need for discussing and developing interventions within the
framework of a pharmaceutical policy.
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Aiming to address the global public health threat caused
by antimicrobial resistance, the World Health Assembly
in 1998 urged member countries to promote the appro-
priate use of antimicrobials by improving prescribing,
dispensing, surveillance and legislation [1]. In the same
year, the Pan American Conference on Antimicrobial
Resistance in the Americas recommended that countries
improve antibiotic use, including restriction on antibiot-
ic sales to prescription-only and education on the proper
use of antibiotics for health professionals and com-
munity members [2]. In 2001, the World Health
Organization (WHO) launched its Global Strategy for
Containment of Antimicrobial Resistance. Recognizing
that isolated interventions have little impact on improv-
ing antibiotic use, the Global Strategy proposed a range
of interventions, organized under the umbrella of na-
tional health and medicine policies [3]. These recom-
mendations were updated in 2011 [4].
Only a few, largely high-income, countries have devel-
oped national strategies to promote appropriate anti-
biotic use; many countries have had difficulty translating
international recommendations into national action
plans. In part, difficulties have resulted from multiple
stakeholder coordination, rigid legal frameworks, and
potential conflicts between guaranteeing access to medi-
cines and assuring rational use [5,6].
Antibiotic policies in Mexico
Mexico is a middle-income country characterized by a
fragmented health care system; expenditure in medicines
occurs largely as out-of-pocket [7]. Until recently, anti-
biotics were among medicines most commonly sold in
private pharmacies (approximately 40% without pre-
scription) [8], and their use for many years exceeded that
of other Latin American countries [9]. Inappropriate
antibiotic prescriptions and lack of enforcement of
prescription-only sales of antibiotics are both well-
documented problems that Mexico shared with other
Latin American countries [8,10]. Inappropriate antibiotic
use and resistance have been very low on the govern-
ment’s policy agenda, partly due to the lack of clear
problem indicators, ignorance of strategies promoted
internationally, and perception by policy makers that ac-
cess to and supply of medicines should receive priority
[6]. A White Paper by the Mexican Ministry of Health
(MOH) proposing a National Pharmaceutical Policy in
2005 argued that regulating medicines sales to
prescription-only by physicians – as stipulated by law
since 1984 – had not been enforced as a measure to pro-
mote access to medicines because universal health care
coverage has not been achieved [11].
In March 2010, the Mexican National Health Council
announced a new policy enforcing the prescription-onlystatus for antibiotic sales. It created an unprecedented
public debate that gained prominence and space in the
media. The announcement followed a declaration by
the Minister of Health in May 2009 − in the midst of the
H1N1 influenza outbreak − associating high mortality
amongst influenza patients with self-medication, particu-
larly with antibiotics [12]. The policy, enacted as a Min-
isterial Agreement, additionally required all antibiotic
prescriptions to be retained and registered in pharma-
cies, and imposed high penalties for non-compliance, in-
cluding rescinding business licenses. Soon after the
announcement, the policy was opened to public discus-
sion in a governmental website. Although several actors
from the private sector declared opposition to the policy,
it was finally approved with only minor changes, one of
them delaying implementation for some months. The
enforcement policy applied to 2,000 medicines – roughly
one fifth of all medicines available commercially in the
country. Drafting and implementing actions to enforce
regulations on antibiotic sales were accompanied by
press round-ups and press bulletins organized by diverse
stakeholders, opinion columns in newspapers, discussion
forums on the internet, and special programmes on
radio and television. This paper analyzes media coverage
of that policy process.
Relevance of media coverage and interest group
participation in the policy process
It has been recognized that the media not only have the
potential to diffuse health information in society and to
influence health behavior and attitudes [13,14], but also
have the potential to influence public perceptions of
health policy issues, the political elite’s policy considera-
tions, and, eventually, the final policy product [15,16].
The media’s primary role in public policy making has
been related to the process of agenda setting, through
the ability to raise and shape issues and public opinion
which, in turn, can impel governments to act [17]. The
way in which issues are discussed in the media influ-
ences how problems are defined and, consequently,
which policy alternatives are considered to address them.
One manner in which the media can shape public opin-
ion of health policy issues is by framing or emphasizing
them in particular ways [18]. Although there is no
consistency in how “framing” is referred to in the litera-
ture, a frame can be considered an emphasis on particu-
lar aspects of a topic [19]. Entman [20] defines framing
as follows: “[to] frame is to select some aspects of a per-
ceived reality and make them more salient in a commu-
nicating text in such a way as to promote a particular
problem definition, causal interpretation, moral evalu-
ation, and/or treatment recommendation.” Policy issues
reported in the media depend on which facts are
reported and which frames are chosen to address them.
Table 1 Newspapers searched and number of articles
included in the analysis
Newspaper Estimated number
of copies sold per day
Number of articles
included in the analysis
El Universal 180, 000 45
Reforma 175, 000 37
El Sol de México 60,500 32
Milenio diario 40,000 30
Excélsior 90,000 24
La Prensa 150, 000 24
Ovaciones 82,082 21
La Jornada 38,759 19
El financiero 72,000 14
El economista 37,000 13
Diario de México 14,500 13
El Gráfico 300,000 11
Uno más uno 67,672 10
La Crónica de Hoy 70,000 9
Impacto 65,000 6
Rumbo de México 225,245 6
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interaction among journalists and elite constituents, so-
cial movements, and scientific bodies; as well as a
frame’s resonance with broader political values
[19,21,22]. De Vreese [19] proposed distinguishing be-
tween “issue specific” frames and “generic” frames which
are not related to a specific topic or a specific cultural or
historical context. Actors use diverse frames to draw at-
tention to issues of concern implying that certain types
of solutions are called for [23]. Elite stakeholders have
significant resources for shaping journalistic frames to
serve their specific interests [21], which include reinfor-
cing the status quo. However, the media can also give
voice to less powerful stakeholders in order to reflect
dissension or give a new direction to a policy debate. As
Entman [20] explains, frames reveal the “imprint of
power” when reflecting the identity of actors and inter-
ests competing to dominate news texts. Because framing
emphasizes one aspect of a problem at the expense of
others, it can restrict public debate on policies in the
range of issues and policy alternatives considered
[15,23].
The objective of this study was to analyze media
coverage of the process that led to the enforcement
policy on antibiotic sales regulations in Mexico focusing,
firstly, on 1) Which themes gained more or less promin-
ence; 2) Which stakeholder groups dominated the public
debate; 3) What were their positions and actions vis-a-
vis the enforcement policy. The results are discussed in
relation to the processes of agenda setting, policy draft-
ing, and policy implementation in order to highlight po-
tential media and stakeholder effects on the overall
development process. Secondly, with this study we
aimed to shed light on the process of policy making for
medicines in Mexico that could be relevant for other
low and middle income countries (LMICs) wishing
to develop policies directed at improving the use of
antibiotics.
Methods
Data sources and collection
We conducted a systematic review of printed newspaper
articles in Mexico using a media service that publishes
daily on its website [24] all Mexican newspaper articles
focussed on pharmaceutical issues. The service searches
text electronically in 11 national newspapers in addition
to seven in the capital district and other important cities.
These newspapers represent the primary print media in
terms of copies sold and political relevance in Mexico
(see Table 1). The key words used for the electronic
search include, among others, “medicines”, “antibiotics”,
“Ministry of Health”, “pharmaceutical industry”, and
“pharmacies”. We manually screened all of the news-
paper articles published between January 2009 andDecember 2010 on the website and included in our
study only those that covered issues related to antibiotic
use or antibiotics sales regulation. The time period cov-
ers three stages of the policy process: 1) policy agenda
setting (01 January 2009 to 24 March 2010); 2) policy
drafting (25 March 2010 to 24 August 2010); and 3) pol-
icy implementation (25 August 2010 to 31 December
2010).
Data analysis
In the identified newspaper articles, we conducted: 1) a
quantitative content analysis to determine the frequency
of topics and stakeholders covered; and 2) a qualitative
content analysis to gain insight into stakeholder posi-
tions and actions in relation to the enforcement policy.
We were interested in the content of the articles rather
than in the presentation of the stories (such as headlines
or graphical images). All articles were coded for the ana-
lysis. To develop the codebook, each author coded 20
articles identifying emerging themes through inductive
reasoning [25]. Those themes were then structured and
sorted into subject categories and each of the codes
defined. The reliability and validity of the codification
was checked by using investigator triangulation with 20
randomly selected newspaper articles. Discrepancies
were discussed and adjustment made to the codebook
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one author using Atlas ti 5.2 software. In addition to the
codebook, each article was coded according to stake-
holders covered by the media: 1) government (execu-
tive); 2) congress (legislative); 3) pharmacies and outlet
associations; 4) pharmaceutical industry; 5) medical
associations; 6) civil society groups; 7) academic institu-
tions; 8) journalists (in editorials and opinion columns);
and 9) private sector other than the pharmaceutical in-
dustry. Finally, each time a stakeholder code was
attached to a newspaper article, it was linked to the cor-
responding subject category so that we could link the
stakeholder with the topics covered.
For the quantitative content analysis, we first calcu-
lated the frequency of thematic categories for each of
the three time periods separately. If a thematic code was
mentioned several times in the same article, we counted
it only once. Secondly, stakeholder appearance was
counted as the number of times a stakeholder was men-
tioned in a newspaper article: the same association or in-
stitution was counted only once per article even if it was
mentioned several times in the same article. We counted
separately different actors in the same stakeholder group
mentioned in the same articles.
In order to understand the position and actions of sta-
keholders in relation to the new policy during each stage
of the policy making process, a qualitative content ana-
lysis was performed of all the notes in which aTable 2 Summary of the codebook
Thematic category Description of the category and subcategorie
Self-medication (SM) Purchase and use of prescription-only-medicines,
to treat viral infections (influenza, other respirator
to the problem of SM, including the new policy t
Antibiotic resistance (AR) Antimicrobial or antibiotic resistance. Subcategori
prescription ii) solutions, ii) using AR as an argum
Prescription (PM) Medical PM of antibiotics. Subcategories: i) unjust
diseases) ii) perception of low quality of PM; iii) n
Economic impact (EI) Direct and indirect EI resulting from the enforcem
and the pharmaceutical industry; ii) EI in the pop
Corruption (CO) Corruption in the pharmaceutical sector derived f
counterfeit medicines; ii) Black market of prescrip
involved in CO.
Regulation (RE) Regulation and policies related to the sales of an
enforcement; ii) processes of drafting and implem
evaluation of the enforcement policy; iv) objectiv
the enforcement policy.
Health System (HS) Functioning of the Mexican health system in rela
problems of the HS; ii) impact of the enforcemen
services for the population without health insuran
Rational use of medicines
(RUM)
Rational use of medicines in the national and inte
recommendations to achieve RUM in Mexico; iii)
adverse reactions (but excluding references relate
Pharmacies (PH) Functioning of pharmacies in relation to antibioti
quality of services provided by pharmacy staff, an
towards the enforcement policy; iv) demand of thstakeholder code appeared. Firstly, we concentrated the
analysis on the voice of stakeholders, particularly
quotes, rather than the voice of journalists (except for
editorials and opinion columns for which we considered
journalists as another stakeholder group). Here, we
looked for statements about the policy and its objec-
tives, and for arguments against or supporting the new
policy. Secondly, we looked, both in the voice of stake-
holders and journalists, for references to specific actions
developed by the actors in relation to the new policy
development. During the analysis, we searched for simi-
larities and differences between actors within the same
stakeholder group, and between different stakeholder
groups.
Results
In total, 322 newspaper articles were included in the
analysis; of them 18 were published during the agenda
setting period, 185 during policy drafting, and 119 dur-
ing implementation. Despite official statements regard-
ing the problem of self-medication with antibiotics and
the need to control antibiotic sales (following the influ-
enza epidemic in 2009), these topics had little media
coverage in the agenda setting period. During the study
period (see Figure 1) we observed two peaks of media
coverage on the topics of antibiotic use and antibiotic
regulation. The first followed the public declaration by a
member of the National Health Council, on 24 Marchs included
including antibiotics, without medical prescription. Subcategories: i) SM
y or gastro-intestinal infections); ii) causes and scope of SM; iii) solutions
o enforce sales regulation.
es: i) causes and scope, including relation to self-medication and
ent to support the new policy to enforce regulation on antibiotic sales.
ified PM of antibiotics (for instance, for influenza and other respiratory
eed to train physicians and improve their PM of antibiotics
ent policy. Subcategories: i) EI in the private sector such as pharmacies
ulation.
rom the enforcement policy. Subcategories: i) Black market of
tions; iii) CO in the process of pharmacy supervision; iv) physicians
tibiotics in Mexico. Subcategories: i) Legislative framework and lack of
enting the enforcement policy; iii) need to develop an impact
e of the enforcement policy; v) need to disseminate information about
tion to antibiotic use or the enforcement policy. Subcategories: i)
t policy on the health services provided in the HS; iii) access to health
ce.
rnational context. Subcategories: i) International guidelines on RUM; ii)
causes and consequences of inappropriate use of antibiotics, including
d solely to self-medication).
c use or the enforcement policy. Subcategories: i) Operation of PH, ii)
d training of pharmacy staff; iii) position of pharmacy associations
e pharmacy associations owners towards the government.
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regulation of antibiotic sales. The second peak coincided
with the start of the enforcement policy (i.e. the Agree-
ment) implementation in August 2010. The newspaper
sections in which the articles appeared were: front page
or front section 36%; business or financial 11%; editorials
and columns 9%; health or society sections 8%; politics
6%; others 30%.
Topics covered by the news media
Overall, the most prominent themes found during the
policy development process were regulation (29%), self-
medication (13%), and economic impact (12%). Rational
use of medicines, medical prescription, and health sys-
tems were least frequently mentioned. Figure 2 shows
the prevalence of each theme category by stage during
the development process.
Agenda setting: "Self-medication" was the most fre-
quent thematic category, particularly the risks of in-
appropriate treatment of respiratory diseases, including
H1N1 influenza, with antibiotics. The second most fre-
quently mentioned thematic category was “regulation,”
with most of the discussion focusing on the lack of en-
forcement for antibiotic sales. The third category, “anti-
biotic resistance,” was covered mainly as a consequence
of self-medication. The need to promote the rational use
of antibiotics – including improving medical prescribing
– was also addressed during this stage.
Policy drafting: “Regulation” was the main thematic
category during this phase, and included sub-categories























MoH declares that a
measure to control the
sales of antibiotic will
be introduced
Figure 1 Monthly coverage on antibiotic use and regulation in Mexicnotes were coded in this category) and the objective of
the enforcement. “Self-medication” and “antibiotic resist-
ance” were frequently mentioned in relation to each
other; both were used as arguments to support the new
policy. The thematic category “pharmacy” was men-
tioned more frequently in relation to the role of pharma-
cies in implementing the policy, and to the demands
made by the pharmacies to the government. The “eco-
nomic impact” of the policy emerged as a theme: almost
two-thirds of the notes mentioned the economic impact
on the retail sector, while less than half referred to the
economic impact on the population. “Corruption” was
mentioned in relation to the risks of prescription falsifi-
cation and counterfeit antibiotics subsequent to the
policy.
Policy implementation: During this period, the theme
“regulation” also dominated media coverage, but in rela-
tion to information and impact of the policy. Increasing
media coverage included the categories “economic im-
pact” on the retail sector, “corruption,” and “pharmacy”.
The category “health system” also gained relevance, with
most of the notes covering the impact of the enforce-
ment on the health system and the inability of health
system capacity to provide health care to the population.
In contrast, discussions about the rational use of medi-
cines became less prominent.
Stakeholders covered by the media
Figure 3 shows the frequency with which stakeholders
were mentioned at each stage of the policy making process.
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Agenda-setting Policy drafting Policy implementation
28.6% 12.7% 12.2% 11.3% 10.4% 9.8% 5.9% 4.8% 4.2%
N=950 references  to categories in newspaper notes
Figure 2 Theme categories covered by the printed media by stage of the policy process.
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health (MOH) and the medicines regulatory authority
(“COFEPRIS”), and to a much lesser extent other minis-
tries. Second ranked were pharmacies and outlet asso-
ciations (23%), particularly the association of independent
pharmacies, “ANAFARMEX”. Editorials and opinion
columns represented 9% of the notes. While academic
institutions (9%), medical associations (6%), and the
pharmaceutical industry (4%) had greater salience during
the first two stages, their presence decreased in the last
phase. In contrast, the coverage of legislators (6%), civil






















34.9% 23.2% 8.7% 8.7%
Figure 3 Printed media coverage of stakeholders by policy stage.particularly consulting agencies) appeared later on in the
policy process.Stakeholder positions and strategies
Ministry of health
The MOH, as the main supporter of the policy, focused
initially on the dangers of self-medication, especially in
relation to influenza, as the main justification for the
policy. Among the first declarations published were: “No
more self-medication damaging the Mexicans” [26]; “. . .





6.4% 6.0% 4.6% 4.1% 3.3%
N=482 references  to stakeholders in newspaper notes
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resistance was also mentioned, linking it only to self-
medication; as the Health Minister explained: “The
regulation is not a caprice. In Mexico, the population is
generating a resistance to antibiotics which arises from
self-medication” [28].
When faced with arguments by other actors against
the policy and the demand to delay its implementation,
the MOH defended the enforcement arguing that access
to medical care was guaranteed with “Seguro Popular,” a
recently-introduced form of health insurance. Even the
Mexican President was quoted supporting the policy
[29]. Later, the MOH recognized the arguments regard-
ing counterfeit prescriptions and the lack of an informa-
tion campaign, declaring that they would be addressed.
Arguments that could have been used to gain support
for the policy, such as protecting against adverse drug
reactions and unnecessary expenses, were scarcely
addressed.
When, because of policy implementation, physician
consultation offices attached to pharmacies began to
emerge, the position of the MOH was portrayed as
vague, and only some statements cautioned the popula-
tion about the quality of these consultations. In contrast,
the MOH stressed the “positive” impact of the policy, de-
claring that a 35% reduction in antibiotic sales had been
achieved [30].
Pharmacies and outlet associations
The position of these groups – as portrayed by the
media – was predominantly against the enforcement
policy. Even though initial statements were generally
favourable (recognizing the problems of self-medication
and antibiotic resistance), later these groups appeared as
leading opponents. Main arguments conveyed were eco-
nomic losses and logistical difficulties for the pharmacies
(now forced to pursue additional tasks when selling anti-
biotics) as well as the negative health and economic
effects particularly on poor populations with scarce ac-
cess to healthcare. Other arguments were that the regu-
lation would foster corruption, namely a black market in
antibiotics and counterfeit prescriptions, as well as false
inspectors blackmailing pharmacies.
Early strategies used against the policy included creat-
ing alliances (among some independent pharmacy asso-
ciations, medicine distributors and outlet associations)
demanding the government delay implementation in
order to develop first a detailed impact assessment. Later
they demanded a public education campaign (to change
the “culture of self-medication”) and the provision of in-
formation systems for pharmacies to facilitate the new
dispensing procedures. The association of independent
pharmacies ANAFARMEX asked the government to
stop the “witch hunt” against them and demanded theprovision of loans to modernize small pharmacies, as
well as the publication of a comprehensive database of
all registered physicians in Mexico to detect false pre-
scriptions. Another association (UNEFARM) organized a
protest at the regulatory agency building against the
regulation and sent a petition to the President. In con-
trast, declarations by large pharmacy chains were very
scarce.
During the implementation period, ANAFARMEX
demanded that the government permit sales of analge-
sics and cold and cough preparations only in pharmacies
(and not in other outlets) as a way of compensating for
economic loss. A later strategy developed by large phar-
macy chains buffered the impact of the regulation by
offering a “discount” on antibiotics, and creating phys-
ician offices attached to pharmacies to offer cheap or
free medical consultation. Independent pharmacy asso-
ciations pointed out that these “express clinics” gener-
ated unfair competition for smaller pharmacies. Six
months after the implementation, four pharmacy chains
plus some independent pharmacies had included con-
sultation offices within drugstores; one large pharmacy
chain declared that each of its 920 branches had physi-
cians who offered free “medical counseling” for over
30,000 consumers each day [31].
Medical professional associations and academic
institutions
According to the media, these stakeholders were pre-
dominantly in favor of the policy, highlighting antimicro-
bial resistance and adverse drug reactions as serious
public health problems. At the same time, they stressed
the need for an integrated action plan to improve med-
ical prescribing, increase public awareness regarding the
prudent use of antibiotics, and professionalize pharma-
cies. Some medical associations mentioned concerns
about limited access to antibiotic prescriptions in poor
rural communities and the quality of care offered in
clinics attached to pharmacies.
During the policy drafting period, the action taken by
these groups included the publication of open letters to
the MOH and dissemination of a policy brief suggesting
priority actions. Excerpts of the policy brief were later
incorporated into the declarations of the MOH and in
the official publication of the Ministerial Agreement.
Congress
Congress ─the Mexican legislative body─ declarations
were scarcely mentioned in the media during the initial
phase and reflected divided positions by political parties.
While legislators of the ruling political party were sup-
portive of the policy, members of opposing parties
stressed the adverse health and economic impact on the
population (now “forced to pay a doctor”) given the
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vices. Some legislators in the Congress tried to promote
an agreement to revoke the policy, arguing that it was “a
restrictive measure that did not correspond with a health
policy for a country facing a political, economic and so-
cial crisis” [32]. Strategies of the Congress to intervene
included the proposal of a law reform to introduce
higher punishments for those who use false prescrip-
tions, and demands to the executive branch of the gov-
ernment to develop information campaigns and an
independent evaluation of the policy impact.
Pharmaceutical industry and other private firms
During the early policy stages, media coverage addressed
the declarations by some national pharmaceutical com-
panies regarding administrative uncertainty around the
policy change, as well as demanding the government de-
velop an impact assessment and delay implementation.
The generic medicines industry underlined the import-
ance of prescribing antibiotics by generic name.
The statements by transnational pharmaceutical com-
panies and consulting agencies were more frequent dur-
ing the implementation period and focused on the high
value of the antibiotic market in Mexico, the resultant
“reconfiguration of the market,” the economic losses that
the pharmaceutical sector would face and the need to re-
invent the pharmacies. Deloitte, a private consulting
agency, suggested that among the new business models
to avoid economic drawbacks for pharmacies were the
“in-situ physicians” [33]. They also warned that other
regulations to control sales of other medicines could be
expected. Except for one company, these groups omitted
the issue of antimicrobial resistance.
Patients and civil society groups
There were only a few declarations by patients and civil
society organizations. Although the media reflected the
views of citizens (in letters to the editors, interviews to
the population, and on-line discussion forums), the
declarations of only one association (“El poder del con-
sumidor”) were reflected in the media. This association
underlined the possible negative effect of the enforce-
ment policy for the poorest populations and stressed the
need to improve access to health care, provide the public
with more information and monitor user fees for private
medical services.
Journalists
During the formulation period, several editorials and
columns discussed the appropriateness of the regulation
in recognizing the conflict between the problems of self-
medication and antimicrobial resistance on one side, and
the problem of low access to and low quality of public
medical services (including long waiting times andmedicines stock outs) on the other. Some columns ques-
tioned the real reasons for the regulation. Interestingly,
many editorials were also critical about the lack of trans-
parency and clear leadership in the process of policy
making. Some editorials also questioned the feasibility of
implementing the regulation in a country inundated by
medicines promotion, where traditionally the law is not
enforced, and there are too few inspectors to supervise
the pharmaceutical sector.
Discussion
The results highlight a number of important points
about media coverage and stakeholder participation in
relation to antibiotic use and the process of regulating
antibiotic sales in Mexico that could be relevant for
other LMICs aiming to develop policies directed to im-
proving the use of medicines.
Even though the theme of regulation dominated
media coverage, the focus was primarily on the problems
of developing the policy, and little, except for self-
medication, about its objectives or its relation to public
health issues. The other dominant themes in media
debates mirrored the voice of the two major stake-
holders involved. On one hand, the MOH defended the
policy by citing the dangers of self-medication with anti-
biotics; on the other, pharmacy associations opposed it,
citing issues of economic impact and corruption. These
divergent frames were scarcely addressed by the media
on the common ground of a wider public debate on ra-
tional use of medicines and pharmaceutical policy. The
emphasis on the problem of self-medication probably
minimized public concerns about new physician offices
attached to pharmacies and contributed to the belief
that, with the policy, problems in antibiotic use had been
solved. This represented a missed opportunity to discuss
in-depth pharmaceutical policies and the development
of a national strategy on antibiotic use. Additionally,
media coverage also represented a missed opportunity to
sensitize the public about the problem of antibiotic re-
sistance and the need to use antibiotics prudently, which
coincides with other studies which stress the scarcity of
key mobilising information on health directed to the
public [34].
Besides the interests and resources of stakeholders, the
predominant themes reflected in news coverage of anti-
biotic use and antibiotic regulation can also be explained
by journalistic conventions. These conventions tend to
favour certain generic frames such as “episodic framing”
[19] in which social issues and public affairs are por-
trayed as limited to events only, and not discussed in a
broader context (e.g. coverage centred on the policy enact-
ment, rather than in the problem of antibiotic use). Other
common generic frames found in our study are “conflict”
(winners and losers, corruption) and “economic
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regional trend characteristic of Latin America of health
news reporting leaning towards frames of political con-
flict [35].
The present study also sheds light on the actors and
processes involved in health and pharmaceutical policy
making in Mexico. The executive government, mainly
the MOH and the medicines regulatory authority domi-
nated media coverage. This agrees with studies portray-
ing the process of public policy making in Mexico as
state-centered, with low levels of pluralistic debate [36].
The scant involvement of the legislature and the fact
that coverage reflected contradictory views of individual
legislators instead of that of an ad-hoc expert commis-
sion also coincides with other studies highlighting the
traditionally weak role of the legislature and its advisory
commissions in decision-making [36,37].
The associations of small independent pharmacies
mostly affected by the regulation were successful in or-
ganizing press round-ups to push their views in media
debates and make specific demands to the government.
These groups also took advantage of this momentum to
advance their own agenda, such as the threat of compe-
tition by pharmacy chains. This coincides with other
authors pointing out that, although Mexico has attained
a media establishment relatively independent of govern-
ment control, it has also been increasingly beholden to
commercial interests [38,39]. However, even when these
association groups had a strong voice, their effect
appears to be limited, suggesting that the influence of
political factors may outweigh media framing effects on
shaping policies, as other studies have pointed up [15].
Large pharmacy chains had a minor presence in media
debates, as did the transnational pharmaceutical com-
panies because their interests might not be greatly
affected by the policy. Some large chains buffered the
impact of the policy by opening new physician offices,
which might have favored the prescription of branded
medicines. Private enterprises largely framed the policy
debate as a business issue, rather than a health issue,
which resulted in a focus on maximizing profits rather
than improving medicines use. This highlights the inher-
ent complexities of pharmaceutical policies competing
with both economic and public health interests.
Academic institutions and medical associations also
took advantage of the policy momentum to push their
own agendas, especially during the agenda setting and
the early drafting periods. They used the media to stress
the need to develop a comprehensive strategy on anti-
biotic use, a theme that had little resonance in the
media, and had little impact on the final policy.
The scarcity of newspaper coverage describing dia-
logue or interaction between interest groups and the
MOH, and the lack of governmental response to thedemands of interest groups (such as developing a public
information campaign), reflect a political context charac-
terized by vertical and closed decision-making. In
addition, remarks in the media and editorials speculating
about the true reasons for the enforcement suggest a
lack of transparency and lack of trust in the authorities.
Traditionally, civil society has had a very marginal role
in decision-making in Mexico [36,37] with the voice of
these actors barely present in media coverage. The ab-
sence of opinions by pharmacist associations can be
explained by the small number of pharmacists working
in private sector pharmacies. The large majority of phar-
macy staff lack university degrees and undergo very little
professional training in pharmaceutical sciences or
related areas [40]. Hence, pharmacy associations with a
business focus rather than professional associations em-
phasizing professional credentials dominated the media
debate.
Our results coincide largely with the findings of an
analysis of printed media coverage of tobacco policies in
Mexico [41] which reported the overwhelming presence
of governmental actors, and limited inclusion of aca-
demic centers and civil society organizations. However,
because the tobacco study included coverage of the de-
velopment of two laws, the presence of actors from the
legislative branch was significantly larger. Interestingly,
our results on actor participation contrast sharply with a
similar study on medicines policy developed in Canada
[15] where civil society was the dominant voice, demon-
strating the strategic use of the media by these groups.
Although Mexico is undergoing a democratic transition,
the experience of media advocacy by academic and civil
society groups is still developing.
Some lessons can be drawn from our study which are
relevant for other low and middle-income countries aim-
ing to develop policies directed at improving antibiotic
use. First, active opposition by some stakeholders to the
enforcement of regulations on antibiotic sales should be
expected, particularly arguing the economic impact on
the population. Actions seeking to counteract the policy
goals include opening physician offices next to pharma-
cies. Second, even if the voices of governmental and
business-related groups are favored in media coverage,
the policy views of other groups can also achieve visibil-
ity in the media which could contribute to a more
informed policy development process. Third, this study
showed that even if governmental action focuses on a
single problem and a single intervention (enforcement
of sales regulations to avoid self-medication), other
related issues will soon arise in public debate. These
issues include access to medicines (a very sensitive issue
for the population), the quality of medical services, the
tracking of prescriptions and verification of their authen-
ticity, and the adverse impact on commercial interests.
Dreser et al. BMC Public Health 2012, 12:1051 Page 10 of 11
http://www.biomedcentral.com/1471-2458/12/1051These concerns highlight the need to discuss and de-
velop interventions within the common framework of
a pharmaceutical policy, and to engage stakeholders
during the policy process. Finally, the scarcity of in-
depth reporting on issues of antibiotic use and regula-
tion in Mexico and Latin America has also been related
to the limited availability of specialized journalism and
independent information sources [39]. To address
these limitations and to generate political priorities on
antimicrobial use and resistance, the South American
Infectious Disease Initiative [42] has worked with the
news media in three countries, resulting in an improve-
ment on the quantity and quality of coverage of these
issues [39], an experience that might be worth replicat-
ing in other countries.
How does the Mexican case compare with other rele-
vant experiences? The cases of India and Brazil, both
middle-income countries that undertook antibiotic pol-
icies contemporaneously to Mexico are worth discussing.
During 2010, international attention turned to the
spread of the New Delhi metallo-beta-lactamase 1
(NDM-1) gene, believed to have originated in India,
which causes several types of bacteria to become resist-
ant. The naming of the gene and a description of its
spread from that country to Europe in an influential
international medical journal was followed by an intense
public debate in India [43]. Controversy triggered action
and, in 2011, the Indian government published the
National Policy for Containment of Antimicrobial
Resistance. The policy included, among many other
interventions, the banning of over-the-counter antibiotic
sales. However, later the government decided to put
this regulation on hold indefinitely, arguing concerns
over access to medicines, particularly in rural areas [44].
In the case of Brazil it was the spread of the multi-
resistant bacterium CRKP (Carbapenem-Resistant
Klebsiella pneumoniae), also followed by the media,
which gave place to the resolution RDC 44/2010 of the
Brazilian regulatory agency, regulating antibiotic sales to
medical prescription only, to be retained at pharmacies.
The resolution, supported by medical groups, faced the
opposition of pharmacy associations, citing scarce access
to medical services for the poorest populations, as
well as the risk of triggering a parallel antibiotic market
[45]. Taken together, the cases of these three countries
underline the relevance of focusing events (influenza
outbreak, NDM-1 and CRKP spread) to place issues of
antibiotic use and resistance on the governmental
agenda. However, these cases also show that an appar-
ently technical issue (regulating antibiotic sales) can be
very politically sensitive – because economic interests
are affected and because of the relation to wider com-
plex societal issues – underlying again the need to dis-
cuss antibiotic policies within the common frameworkof a pharmaceutical policy, and to mobilize political
support.
Our study presents some limitations. First, our analysis
used a unique coding scheme (“issue-specific” instead of
“generic” frames) which limits our ability to generalize
and compare the results [19]. However, whenever pos-
sible, we discussed our coding scheme in relation to gen-
eric frames. Other limitations concern excluding an
analysis of electronic media (radio, television and inter-
net) which are important in Mexico and other countries
in the region [39] as well as the fact that our analysis
was limited to the period of only five months after policy
implementation. Relevant discussions and stakeholder
actions that might have appeared later in the policy
process or in other media outlets were excluded. Finally,
as others pointed out, we can describe the representa-
tion of issues and stakeholder participation in the media,
but we can only infer their potential effects on the pub-
lic and on the policy process [15]. To provide a more
comprehensive picture of stakeholder participation in
the policy process it is necessary to use alternative data
sources.
Conclusions
Aspects of greater salience on media coverage were the
issue of self medication used to justify the policy to en-
force antibiotic sales regulations, and the negative
aspects (economic impact and corruption) which largely
represented the views of the two main stakeholders in
the debate. Neither of these perspectives was conducive
to public discussion on the wider problems of antibiotic
misuse and resistance. Because framing emphasizes
some aspects of the issues at the expense of others, the
extensive coverage of the conflicts around developing
and implementing the enforcement policy left little room
to discuss wider societal issues, with the exception of
discussions concerning access to medicines and health
services. The absence of debate on the relationship be-
tween the policy and promoting rational use of medi-
cines, improving the quality of services provided in
pharmacies, and addressing the global public health
threat posed by antimicrobial resistance meant a missed
opportunity for discussing and developing a comprehen-
sive national strategy on antibiotic use in Mexico.
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